Level D· Scientific groundwork from lab and animal studiesNarrative ReviewEurope PMC

Indeterminate-Depth Burn Injury-Exploring the Uncertainty

Karim AS., Shaum K., Gibson ALF.

Narrative Review on Chronic Wound, Burns, Scar, published in J Surg Res (2020) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Narrative Review
Journal
J Surg Res (2020)
Reported sample size
—
Source database
Europe PMC
PMID
31421361
PMCID
PMC8711117
DOI
10.1016/j.jss.2019.07.063
Citations
30

Abstract (original English)

In the management of indeterminate-depth burns (IDB), common challenges include the ability to predict time to healing and regenerative potential, risk of burn wound progression, and timing of excision. Several technologies exist to aid in determination of the depth of a burn injury, yet surgeons continue to rely on the naked eye-visual assessment-as the standard of care. Newer and improved imaging technologies are closing in on the goal of inexpensive, accurate, noninvasive modalities for depth determination. Likewise, management of IDB is becoming more sophisticated as newer wound healing technologies continue to be developed. By describing what is meant by "indeterminate" depth burns, and their associated challenges, we hope to stimulate interest in research to develop new therapies and management strategies. The ultimate goal is to treat IDB without the need for autografts.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is a narrative review: it collects no new patient data and does not systematically appraise evidence quality.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
SkinHumansBurnsDisease ProgressionTreatment OutcomeDebridementSkin TransplantationSeverity of Illness IndexUncertaintySkin, Artificial

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research